| Date | Hs Code | Spanish Product Description | English Product English | Quantity | Measure Unit | Chile Exporter Name | Destination Country | Details |
|---|---|---|---|---|---|---|---|---|
| 18-01-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 9.57 | KILOGRAMOS NETOS |  LA******.A. | PARAGUAY | |
| 11-02-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 8.7 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 19-02-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOCOLESTEROLEMIANTES PRINCIPIO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS CHOLESTEROL-LOWERING CHOLESTEROL ABSORPTION ACTIVE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 26.4 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 19-02-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOCOLESTEROLEMIANTES PRINCIPIO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS CHOLESTEROL-LOWERING CHOLESTEROL ABSORPTION ACTIVE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 17.6 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 27-02-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 6.22 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 27-02-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 12.44 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 07-03-2019 | 29061300 | ESTEROLES E INOSITOLES. COLESTEROL SFCOMERC.NUTRECO CHILE LTDA. - FESTEROLES E INOSITOLES | STEROLS AND INOSITOL. CHOLESTEROL SFCOMERC.NUTRECO CHILE LTDA. - FESTEROLES E INOSITOL | 3922 | KILOGRAMOS NETOS | ****** | ECUADOR | |
| 08-03-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 73.4 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 08-03-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTES PRINCIPIO ACTIVO ROSUVASTATINA MEDICAMENTO PARA CONSUMO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE FOR HUMAN CONSUMPTION ROSUVASTATIN MEDICINAL | 17.2 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 20-03-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.24 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 20-03-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.5 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 28-03-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.24 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 28-03-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.49 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 02-05-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.62 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 02-05-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.49 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 02-05-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 8.08 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 17-05-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPIMIANTES PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTODE USO HUMANO | CONTAINING INHIBITORS HYPOLIPEMIANT CHOLESTEROL ABSORPTION ROSUVASTATIN MEDICAMENTODE ACTIVE PRINCIPLE FOR HUMAN USE | 33.2 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 17-05-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 49 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 03-06-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.24 | KILOGRAMOS NETOS | ****** | BOLIVIA | |
| 03-06-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.75 | KILOGRAMOS NETOS | ****** | BOLIVIA | |
| 18-06-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 62.6 | KILOGRAMOS NETOS | LA******.A. | COSTA RICA | |
| 02-07-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 9.33 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 03-07-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 164.1 | KILOGRAMOS NETOS | LA******.A. | COSTA RICA | |
| 08-07-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 1.49 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 08-07-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.62 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 11-07-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 8.7 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 11-07-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | STATINS AND CHOLESTEROL-LOWERING CONTAINING DERIVATIVES BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 9.57 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 22-07-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVOROSUVASTATINA MEDICAMENTO DEUSO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION MEDICINAL HUMAN PRINCIPLE ACTIVOROSUVASTATINA DEUSO | 79.3 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 23-07-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIENTES PRINCIPIO ACTIVO ROSUVASTATINA USO HUMANO | CONTAINING INHIBITORS HIPOLIPEMIENTES PRINCIPLE CHOLESTEROL ABSORPTION ROSUVASTATIN ACTIVE HUMAN USE | 38.8 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 23-07-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 36.3 | KILOGRAMOS NETOS | LA******.A. | ECUADOR | |
| 24-07-2019 | 30049062 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION ACTIVE PRINCIPLE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 151.7 | KILOGRAMOS NETOS | LA******.A. | COSTA RICA | |
| 07-08-2019 | 15161011 | GRASAS, ACEITES Y SUS FRACCIONES DE PESCADO GRASAGOLDEN OMEGA S.A-FDETOX FOC-27(CONTIENE NO MENOS QUE EL 25%DE COLESTEROL) EN 1 ISOTANQUE | FATS, OILS AND THEIR FRACTIONS OF FISH OMEGA GRASAGOLDEN S.A-FDETOX FOC-27 (CONTAINING NOT LESS THAN 25% CHOLESTEROL) IN 1 ISOTANQUE | 21840 | KILOGRAMOS NETOS | ****** | INDIA | |
| 13-08-2019 | 15161011 | GRASAS, ACEITES Y SUS FRACCIONES DE PESCADO GRASAGOLDEN OMEGA S.A-FDETOX FOC-27(CONTIENE NO MENOS QUE EL 25%DE COLESTEROL) EN 1 ISOTANQUE | FATS, OILS AND THEIR FRACTIONS OF FISH OMEGA GRASAGOLDEN S.A-FDETOX FOC-27 (CONTAINING NOT LESS THAN 25% CHOLESTEROL) IN 1 ISOTANQUE | 21670 | KILOGRAMOS NETOS | ****** | INDIA | |
| 07-10-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MENORUSO HUMANO | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X HUMAN MENORUSO | 1.49 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 16-10-2019 | 15161011 | GRASAS, ACEITES Y SUS FRACCIONES DE PESCADO GRASAGOLDEN OMEGA S.A-FDETOX FOC-27(CONTIENE NO MENOS QUE EL 25%DE COLESTEROL)EN 1 ISOTANQUE | FATS, OILS AND THEIR FRACTIONS OF FISH OMEGA GRASAGOLDEN S.A-FDETOX FOC-27 (CONTAINING NOT LESS THAN 25% CHOLESTEROL) IN 1 ISOTANQUE | 20530 | KILOGRAMOS NETOS | ****** | INDIA | |
| 23-10-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MENORUSO HUMANO | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X HUMAN MENORUSO | 1.87 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 23-10-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MENORUSO HUMANO | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X HUMAN MENORUSO | 0.75 | KILOGRAMOS NETOS | LA******.A. | BOLIVIA | |
| 23-10-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MENORUSO HUMANO | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X HUMAN MENORUSO | 5.6 | KILOGRAMOS NETOS | LA******.A. | PARAGUAY | |
| 26-11-2019 | 30049061 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 10 MG MED.DOSIF.Y ACOND.VTA.X ME | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 10 MG MED.DOSIF.Y ACOND.VTA.X ME | 2.18 | KILOGRAMOS NETOS | ****** | PARAGUAY | |
| 07-12-2019 | 160000 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.62 | KILOGRAMOS NETOS | ****** | BOLIVIA | |
| 10-12-2019 | 160000 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 20 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.62 | KILOGRAMOS NETOS | ****** | BOLIVIA | |
| 10-12-2019 | 160000 | QUE CONTENGAN ESTATINAS Y SUS DERIVADOS HIPOCOLESTEROLEMIANTES BASE: ATORVASTATINA CALCICA 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | CONTAINING DERIVATIVES CHOLESTEROL-LOWERING STATINS AND BASE: ATORVASTATIN CALCIUM 40 MGMED.DOSIF.Y ACOND.VTA.X MEN | 0.75 | KILOGRAMOS NETOS | ****** | BOLIVIA | |
| 20-12-2019 | 08094019 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTE PRINCIPO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS OF CHOLESTEROL ABSORPTION PRINCIPLE ACTIVE HYPOLIPIDEMIC ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 374.5 | KILOGRAMOS NETOS | ****** | COSTA RICA | |
| 26-12-2019 | 22042169 | QUE CONTENGAN INHIBIDORES DE LA ABSORCION DEL COLESTEROL HIPOLIPEMIANTES PRINCIPIO ACTIVO ROSUVASTATINA MEDICAMENTO DE USO HUMANO | CONTAINING INHIBITORS LIPID LOWERING CHOLESTEROL ABSORPTION PRINCIPLE ACTIVE ROSUVASTATIN MEDICINAL PRODUCTS FOR HUMAN USE | 389.5 | KILOGRAMOS NETOS | SO******S.A | COSTA RICA |
Loading ....